ClinicalTrials.gov
public full text
Public Domain
Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI
Acute myocardial infarction is generally caused by a thrombotic occlusion of coronary arteries. Primary aim of early therapy is a fast and complete reperfusion of the infarcted myocardium.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Add-on Cangrelor in STEMI-triggered Cardiac Arrest#864166
- Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size#865760
- Aggregometry in Elderlies With Hip Fracture and Receiving Clopidogrel#1031103
- Tailored Antiplatelet Therapy Following PCI#1087103
- Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial Infarction#847796
Record · ID 1164049
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive